AHRP Press Statement – FDA & SSRI Suicide Risk 9/14/04

ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.ahrp.org ***PRESS STATEMENT*** Re: The FDA & Concealment of Suicide-Related Risks of Antidepressants Date: September 14, 2004 Contact: Vera Hassner Sharav, President   We are witnessing the unraveling of a system that was intended to ensure that marketed drugs met high safety standards; that…

Press Statement – FDA & Concealment of Suicide-Related Risks of Antidepressants

We are witnessing the unraveling of a system that was intended to ensure that marketed drugs met high safety standards; that physicians were informed about potential, serious adverse drug effects – so that they would prescribe judiciously; and that the integrity of the scientific literature was preserved. But that system has been hijacked by the drug industry – which has infected medical practice and medical research with detail men and informercials that make false claims while manipulating partial data to conceal adverse drug effects.